Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: May 28, 2009

Premium

NIH Grants in Proteomics, April 14 – May 12, Pt. 1

Principal Investigator: Akhtari, Saeid
Organization: NextBio
Title: Cross-species Meta-analysis Tool for High-Throughput Genomic and Proteomic Resear[ch]
Start Date: Aug. 10, 2006
End Date: March 31, 2011
Amount in FY 2009: $489,491


Principal Investigator: Amaya, Kensey Rafael
Organization: University of Illinois, Urbana-Champaign
Title: Mass Spectrometric Imaging of Molecular Distributions in the Brain
Start Date: Feb. 16, 2008
End Date: Feb. 15, 2010
Amount in FY 2009: $41,176


Principal Investigator: Andrews, William Walton
Organization: University of Alabama, Birmingham
Title: Genomic/Proteomic PTB Network: UAB Clinical Core Center
Start Date: March 1, 2006
End Date: Jan. 31, 2011
Amount in FY 2009: $179,420


Principal Investigator: Angeletti, Ruth Hogue
Organization: Yeshiva University
Title: Pilot Proteomics Center on Drug Abuse HIV/AIDS
Start Date: May 1, 2009
End Date: Feb. 28, 2012
Amount in FY 2009: $995,400


Principal Investigator: Bansal, Rashmi
Organization: University of Connecticut School of Medicine and Dentistry
Title: Proteomic Mapping of Myelin and its Membrane Subdomains
Start Date: Sept. 30, 2000
End Date: Feb. 28, 2010
Amount in FY 2009: $442,912


Principal Investigator: Baraniuk, James N
Organization: Georgetown University
Title: Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome
Start Date: July 14, 2006
End Date: April 30, 2010
Amount in FY 2009: $366,587

[ pagebreak ]

Principal Investigator: Bartlett, Michael Griffith
Organization: University of Georgia
Title: Q-TOF Ion Mobility Mass Spectrometer for Drug Discovery
Start Date: May 1, 2009
End Date: April 30, 2010
Amount in FY 2009: $500,000


Principal Investigator: Bosron, William F
Organization: Indiana University-Purdue University at Indianapolis
Title: Quantification of Human Alcohol Metabolizing Enzymes by Mass Spectrometry
Start Date: April 15, 2008
End Date: March 31, 2010
Amount in FY 2009: $179,313


Principal Investigator: Bowler, Russell Paul
Organization: National Jewish Health
Title: Metabolome and Proteome Profiles of Emphysema and Airway Disease
Start Date: April 9, 2009
End Date: March 31, 2013
Amount in FY 2009: $390,000


Principal Investigator: Brown, Lewis M
Organization: Columbia University
Title: Difference Gel Electrophoresis System for Proteomics
Start Date: March 1, 2009
End Date: Feb. 28, 2010
Amount in FY 2009: $121,961


Principal Investigator: Bukowski, Radoslaw K
Organization: University of Texas Medical Branch, Galveston
Title: Genomic/Proteomic Premature Birth Research Clinical Core
Start Date: Feb. 1, 2006
End Date: Jan. 31, 2011
Amount in FY 2009: $196,265

[ pagebreak ]

Principal Investigator: Chait, Brian T
Organization: Rockefeller University
Title: Nat[iona]l Resource for Mass Spectrom[etry] of Biolog[ical] Macromolecules
Start Date: Dec. 23, 2006
End Date: Feb. 29, 2012
Amount in FY 2009: $1,322,308


Principal Investigator: Mark Chance
Organization: Case Western Reserve University
Title: Case Proteomics Center for HIV/AIDS and Drug Abuse
Start Date: April 15, 2009
End Date:March 31, 2012
Amount in FY 2009: $989,108


Principal Investigator: Chen, Sixue
Organization: University of Florida
Title: Establishment of a High Performance UPLC-QSTAR Elite Proteomics Platform at Unive[rsity of Florida]
Start Date: May 1, 2009
End Date: April 30, 2010
Amount in FY 2009: $326,049


Principal Investigator: Chien, Peter
Organization: Massachusetts Institute of Technology
Title: Specificity, Regulation and Proteomic Profiling of an Essential AAA+ Protease
Start Date: April 1, 2008
End Date: March 31, 2010
Amount in FY 2009: $90,000


Principal Investigator: Cooks, Robert
Organization: Purdue University
Title: Tissue Imaging Using Desorption Electrospray Ionization Mass Spectrometry
Start Date: April 1, 2009
End Date: March 31, 2011
Amount in FY 2009: $206,997

[ pagebreak ]

Principal Investigator: Cotter, Robert J
Organization: Johns Hopkins University
Title: Pilot Proteomics Center for HIV-Related Dementia and Drug Abuse
Start Date: April 1, 2009
End Date: March 31, 2011
Amount in FY 2009: $246,000


Principal Investigator: Cotter, Robert J
Organization: Johns Hopkins University
Title: Purchase of a Triple Quadrupole Mass Spectrometer for Multiple Reaction Monitorin[g]
Start Date: May 1, 2009
End Date: April 30, 2010
Amount in FY 2009: $413,070


Principal Investigator: Cravatt, Benjamin F
Organization: Scripps Research Institute
Title: Chemical Approaches for Activity-based Proteomics
Start Date: July 1, 2000
End Date: Feb. 28, 2014
Amount in FY 2009: $340,314


Principal Investigator: Didonato, Joseph
Organization: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Title: Triple Quadrupole/Linear ion TRAP Mass Spectrometer with HPLC System
Start Date: April 1, 2009
End Date: March 31, 2010
Amount in FY 2009: $500,000


Principal Investigator: Elenitobajohnson, Kojo Seys
Organization: University of Michigan
Title: Proteomic Analysis of API2-Malt1 Positive Gastric Malt Lymphoma
Start Date: March 26, 2009
End Date: Jan. 31, 2014
Amount in FY 2009: $289,184

[ pagebreak ]

Principal Investigator: Engel, Joanne N
Organization: University of California, San Francisco
Title: Proteomic Approach to Identify Mediators of PI3K Activation by P. aeruginosa
Start Date: April 1, 2008
End Date: March 31, 2011
Amount in FY 2009: $37,901


Principal Investigator: Esko, Jeffrey D
Organization: University of California, San Diego
Title: Shared Instrumentation Grant: LTQ Linear Ion Trap Mass Spectrometer
Start Date: May 1, 2009
End Date: April 30, 2010
Amount in FY 2009: $420,055


Principal Investigator: Frechet, Jean M
Organization: University of California, Berkeley
Title: Microfluidic Systems with Monoliths Enabling Sample Preparation in Proteomics
Start Date: June 1, 2006
End Date: March 31, 2010
Amount in FY 2009: $321,403


Principal Investigator: Goldman, Radoslav
Organization: Georgetown University
Title: Proteomic Analysis of Serum in Liver Cancer
Start Date: Feb. 15, 2007
End Date: Jan 31, 2011
Amount in FY 2009: $338,358


Principal Investigator: Gygi, Steven P
Organization: Harvard University
Title: Mass Spectrometry-Based Approaches to Study Protein Ubiquitination
Start Date: May 15, 2003
End Date: Jan. 31, 2013
Amount in FY 2009: $486,582

[ pagebreak ]

Principal Investigator: Han, James
Organization: Ambergen
Title: Mass Spectrometric Detection of Drug-Resistant HIV
Start Date: March 1, 2004
End Date: March 31, 2010
Amount in FY 2009: $848,937


Principal Investigator: Hansen, Kirk C
Organization: University of Colorado, Denver
Title: LTQ Orbitrap Mass Spectrometer Request
Start Date: April 1, 2009
End Date: March 31, 2010
Amount in FY 2009: $500,000


Principal Investigator: Huang, Lan
Organization: University of California, Irvine
Title: Proteomics of the Proteasome Interacting Networks
Start Date: Aug. 1, 2005
End Date: July 31, 2010
Amount in FY 2009: $37,886


Principal Investigator: Iandolo, John J
Organization: University of Oklahoma Health Sciences Center
Title: Functional Genome/Proteomic Analysis of Pathogen-Host Interactions
Start Date: Sept. 15, 2000
End Date: Feb. 28, 2010
Amount in FY 2009: $1,915,718


Principal Investigator: Jackson, George W
Organization: BioTex
Title: Rapid Microbial Identification by MALDI-TOF Mass Spectrometry of Ribosomal RNA
Start Date: Aug. 1, 2005
End Date: Feb. 28, 2011
Amount in FY 2009: $396,675

[ pagebreak ]

Principal Investigator: Josic, Djuro
Organization: Rhode Island Hospital
Title: Ultraspec III TOF/TOF 200 MALDI-TOF Mass Spectrometry Imaging System
Start Date: May 1, 2009
End Date: April 30, 2010
Amount in FY 2009: $499,702


Principal Investigator: Karin, Norman J
Organization: Battelle Pacific Northwest Laboratories
Title: Proteomic Analysis of Osteocytes
Start Date: April 1, 2008
End Date: March 31, 2010
Amount in FY 2009: $181,950


Principal Investigator: Karnik, Sadashiva S
Organization: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Title: Phosphoproteome and Ang II-induced VSMC Gene Expression
Start Date: Feb. 1, 2006
End Date: Jan. 31, 2011
Amount in FY 2009: $300,039


Principal Investigator: Kelleher, Neil L
Organization: University of Illinois, Urbana-Champaign
Title: Mass Spectrometric Studies of Thiotemplate Biosynthesis
Start Date: May 1, 2003
End Date: June 30, 2010
Amount in FY 2009: $214,007


Principal Investigator: Kiernan, Urban A
Organization: Intrinsic Bioprobes
Title: MS-based Approaches for Diabetes Biomarker Discovery
Start Date: June 1, 2005
End Date: Sept. 30, 2009
Amount in FY 2009: $261,947

[ pagebreak ]

Principal Investigator: Kohlstaedt, Lori
Organization: University of California, Berkeley
Title: LTQ XL Linear Quadrupole Ion Trap Mass Spectrometer
Start Date: April 1, 2009
End Date: March 31, 2010
Amount in FY 2009: $463,425


Principal Investigator: Kourakine, Alexei
Organization: Beth Israel Deaconess Medical Center
Title: Proteomic Analysis of Amyloid Precursor Protein Signaling: Mediators of Toxicity
Start Date: March 1, 2008
End Date: Feb. 28, 2010
Amount in FY 2009: $222,987


Principal Investigator: Lechene, Claude P
Organization: Brigham and Women's Hospital
Title: National Resource for Imaging Mass Spectrometry
Start Date: Sept. 1, 2003
End Date: Aug. 31, 2013
Amount in FY 2009: $55,000


Principal Investigator: Li, Lingjun
Organization: University of Wisconsin
Title: Mass Spectrometric Studies of Neuropeptides in Feeding
Start Date: May 1, 2003
End Date: April 30, 2011
Amount in FY 2009: $291,607


Principal Investigator: Li, Zhong
Organization: University of Illinois, Urbana-Champaign
Title: Acquisition of a Triple Quadrupole Mass Spectrometer
Start Date: April 1, 2009
End Date: March 31, 2010
Amount in FY 2009: $468,837


Principal Investigator: Lim, Mark
Organization: Ambergen
Title: Novel Proteomic Arrays of In Vitro Expressed Proteins for Autoimmune Disease
Start Date: Sept. 1, 2002
End Date: March 31, 2010
Amount in FY 2009: $657,583

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.